CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 137 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $6,272,000 | -0.6% | 239,742 | -33.9% | 1.53% | +15.9% |
| Q3 2020 | $6,309,000 | -8.6% | 362,497 | -11.7% | 1.32% | -3.9% |
| Q2 2020 | $6,902,000 | -7.0% | 410,330 | -34.2% | 1.38% | +19.6% |
| Q1 2020 | $7,418,000 | -5.7% | 623,915 | -4.1% | 1.15% | +53.1% |
| Q4 2019 | $7,868,000 | -37.6% | 650,275 | -27.1% | 0.75% | -21.1% |
| Q3 2019 | $12,603,000 | +54.8% | 891,636 | +22.1% | 0.95% | +63.7% |
| Q2 2019 | $8,142,000 | +163.3% | 730,188 | +177.2% | 0.58% | +158.7% |
| Q1 2019 | $3,092,000 | -99.8% | 263,396 | +163.3% | 0.22% | +108.3% |
| Q4 2018 | $1,336,388,000 | +232.4% | 100,029 | +380.2% | 0.11% | +217.6% |
| Q3 2017 | $402,058,000 | +49.5% | 20,832 | -8.6% | 0.03% | +36.0% |
| Q2 2017 | $268,875,000 | -11.0% | 22,786 | -17.3% | 0.02% | -16.7% |
| Q1 2017 | $301,948,000 | – | 27,550 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |